Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
D000818:Animals; D000914:Antibodies, Viral; D000917:Antibody Formation; D000956:Antigens, Viral; D003168:Complement Fixation Tests; D003429:Cross Reactions; D005557:Formaldehyde; D006168:Guinea Pigs; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral; D006723:Hong Kong; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology*; D009439:Neuraminidase / Q000378:metabolism*; D009975:Orthomyxoviridae / Q000201:enzymology* / Q000276:immunology; D013624:Taiwan
D000914:Antibodies, Viral; D000956:Antigens, Viral; D006389:Hemagglutinins, Viral; D007252:Influenza Vaccines; D005557:Formaldehyde; D009439:Neuraminidase